<DOC>
	<DOCNO>NCT00232687</DOCNO>
	<brief_summary>The purpose clinical research study evaluate safety tolerability two switch strategy risperidone aripiprazole period 12 week out-patients treat general psychiatric practice set currently experience efficacy and/or safety/tolerability issue risperidone .</brief_summary>
	<brief_title>A Switch Study BMS-337039 Schizophrenic Out-patients</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Patients diagnosis schizophrenia define DSMIVTR2 criterion Outpatients take Risperidone minimum 6 week optimally control and/or experience safety/tolerability issue Risperidone Men woman , age 18 65 year Patients risk commit suicide Patients diagnosis schizoaffective disorder , bipolar disorder , depression psychotic symptom , organic brain syndrome Meeting DSMIVTR criterion significant Psychoactive Substance Use Disorder within 3 month prior Screening Treatmentresistant antipsychotic medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>